EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
13.08.24
/
50%
€7.68
Target price
13.08.25
€26.50
Performance (%)
-7.92%
Price
14.08.24
€7.07
Summary
This prediction is currently active. With a performance of -7.92%, the BUY prediction for EyePoint Pharmaceuticals Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 13.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
EyePoint Pharmaceuticals Inc. | -7.92% |
iShares Core DAX® | 2.722% |
iShares Nasdaq 100 | 4.546% |
iShares Nikkei 225® | 6.353% |
iShares S&P 500 | 3.194% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.46
04.06.24
04.06.24
€29.43
04.06.25
04.06.25
-18.54%
14.08.24
14.08.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.60
22.01.24
22.01.24
€32.12
22.01.25
22.01.25
-68.11%
14.08.24
14.08.24